Form 6-K Telix Pharmaceuticals For: Sep 21

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/30/2026

1. INTC
2. AMZN
3. RDDT
4. PINS
5. COIN
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

September 21, 2026 8:56 AM EDT
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of September, 2026
 
Commission File Number: 001-42128
 
Telix Pharmaceuticals Limited
(Translation of registrant’s name into English)
 
55 Flemington Road
North Melbourne, Victoria 3051, Australia
(Address of principal executive offices)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-
F.
 
Form 20-F ☒ Form 40-F ☐
 
 
INFORMATION CONTAINED IN THIS FORM 6-K REPORT
 
On September 21, 2026 (Melbourne, Australia), Telix Pharmaceuticals Limited ("Telix") filed the following
announcements with the Australian Securities Exchange titled: (i) “Telix and ITM Join Forces to Create a
Radiopharmaceutical Powerhouse” and (ii) "Telix + ITM A radiopharmaceutical powerhouse with enhanced
capabilities across the value chain" copies of which are attached to this Form 6-K as Exhibit 99.1 and Exhibit 99.2,
respectively.
The information contained in this Form 6-K, except for information accessible by hyperlinks included therein, are
incorporated by reference into Telix’s Registration Statement on Form S-8 (File No. 333-283917).
Press release – September 21, 2026
Investor presentation – September 21, 2026
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
 
Telix Pharmaceuticals Limited
Date:
September 21, 2026
By:
/s/ Christian Krautkramer
Name: Christian Krautkramer
Title: Group General Counsel
 
 
 
 

ATTACHMENTS / EXHIBITS

EX-99.1

EX-99.2


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

SEC Filings